Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 5
1999 13
2000 12
2001 4
2002 7
2003 8
2004 5
2005 8
2006 3
2007 4
2008 5
2009 7
2010 9
2011 6
2012 7
2013 11
2014 10
2015 12
2016 10
2017 19
2018 25
2019 18
2020 31
2021 21
2022 38
2023 46
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK, Talukder M, Williams G. Gupta AK, et al. J Dermatolog Treat. 2022 Nov;33(7):2946-2962. doi: 10.1080/09546634.2022.2109567. Epub 2022 Aug 15. J Dermatolog Treat. 2022. PMID: 35920739 Review.
BACKGROUND: Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. ...EFFICACY AND SAFETY: A probable efficacy ranking, in decreasing order, is - dutasteride 0.5 mg/d, finasteride 5 mg/d, minoxidil 5 mg/d, fin …
BACKGROUND: Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. ...EFFICACY AND SAF …
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Nestor MS, et al. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. J Cosmet Dermatol. 2021. PMID: 34741573 Free PMC article. Review.
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's quality of life. ...MATER …
BACKGROUND: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal h …
Androgenetic Alopecia: Therapy Update.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Devjani S, et al. Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11. Drugs. 2023. PMID: 37166619 Free PMC article. Review.
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form of alopecia worldwide, and arises from an excessive response to androgens. ...There are only two US Food and Drug Administrati …
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most commo …
Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.
Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Kaiser M, et al. Clin Cosmet Investig Dermatol. 2023 May 31;16:1387-1406. doi: 10.2147/CCID.S385861. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37284568 Free PMC article. Review.
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding mixed results. ...
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Traditionally, topical minoxidil an …
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. Lee SW, et al. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. J Drugs Dermatol. 2018. PMID: 29601622 Free PMC article. Review.
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of androgenetic alopecia. ...
INTRODUCTION: Currently, only topical minoxidil (MNX) and oral finasteride (FNS) are approved by the Food and Drug Administrat …
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. Suchonwanit P, et al. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20. J Eur Acad Dermatol Venereol. 2018. PMID: 29972712 Clinical Trial.
BACKGROUND: The synergism of combined use between oral finasteride and topical minoxidil has been established in treating androgenetic alopecia among men. ...METHODS: Forty men aged 18-60 years with androgenetic alopecia were randomized t …
BACKGROUND: The synergism of combined use between oral finasteride and topical minoxidil has been established in treating a …
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil(), Finasteride(), and Adult Stem Cell-Based Therapy.
Gentile P, Garcovich S. Gentile P, et al. Int J Mol Sci. 2020 Apr 13;21(8):2702. doi: 10.3390/ijms21082702. Int J Mol Sci. 2020. PMID: 32295047 Free PMC article.
The number of articles evaluating platelet-rich plasma (PRP) efficacy in androgenic alopecia (AGA) have exponentially increased during the last decade. ...The information analyzed highlights the positive effects of PRP on AGA, without major side effects and thus it be may …
The number of articles evaluating platelet-rich plasma (PRP) efficacy in androgenic alopecia (AGA) have exponentially increased durin …
Relative Efficacy of Minoxidil and the 5-alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Gupta AK, et al. JAMA Dermatol. 2022 Mar 1;158(3):266-274. doi: 10.1001/jamadermatol.2021.5743. JAMA Dermatol. 2022. PMID: 35107565 Free PMC article.
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-alpha reductase inhibitors dutasteride and finasteride. OBJECTIVE: To examine the relative ef …
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), …
Genetic and molecular aspects of androgenetic alopecia.
Martinez-Jacobo L, Villarreal-Villarreal CD, Ortiz-López R, Ocampo-Candiani J, Rojas-Martínez A. Martinez-Jacobo L, et al. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):263-268. doi: 10.4103/ijdvl.IJDVL_262_17. Indian J Dermatol Venereol Leprol. 2018. PMID: 29595184 Free article. Review.
Androgenetic alopecia is the most common form of progressive hair loss in humans. ...Several recent advances in molecular biology and genetics have increased our understanding of the mechanisms of hair loss in androgenetic alopecia. We review these adv …
Androgenetic alopecia is the most common form of progressive hair loss in humans. ...Several recent advances in molecular biol …
Natural products for male androgenetic alopecia.
Gupta AK, Talukder M, Bamimore MA. Gupta AK, et al. Dermatol Ther. 2022 Apr;35(4):e15323. doi: 10.1111/dth.15323. Epub 2022 Jan 27. Dermatol Ther. 2022. PMID: 35044013 Review.
Androgenetic alopecia (AGA) is the most common cause of hair loss in men, often requiring medical attention. The US FDA approved topical minoxidil and oral finasteride to treat AGA. Topical minoxidil requires a long-term application to observe i …
Androgenetic alopecia (AGA) is the most common cause of hair loss in men, often requiring medical attention. The US FDA approv …
321 results